AAPL315.34-0.88 (-0.28%) ▼|ABBV250.91+2.13 (+0.86%) ▲|ABT105.23-0.29 (-0.27%) ▼|ACN175.80-3.23 (-1.80%) ▼|ADBE254.86-2.40 (-0.93%) ▼|AMAT468.85-3.94 (-0.83%) ▼|AMD521.10+15.36 (+3.04%) ▲|AMGN391.27-1.90 (-0.48%) ▼|AMT175.43-0.30 (-0.17%) ▼|AMZN252.40-4.57 (-1.78%) ▼|AVGO364.38-4.18 (-1.13%) ▼|AXP321.80-4.30 (-1.32%) ▼|BA206.42-4.31 (-2.05%) ▼|BAC62.67+0.28 (+0.45%) ▲|BKNG173.43-6.87 (-3.81%) ▼|BLK1,072.03-23.34 (-2.13%) ▼|BMY64.41-0.28 (-0.43%) ▼|BNY162.51-0.34 (-0.21%) ▼|BRK-B506.72+0.89 (+0.18%) ▲|C137.80+1.06 (+0.78%) ▲|CAT815.56-6.92 (-0.84%) ▼|CL88.03-0.38 (-0.43%) ▼|CMCSA24.59-1.74 (-6.61%) ▼|COF210.86-3.10 (-1.45%) ▼|COP136.53+1.49 (+1.10%) ▲|COST902.60-7.58 (-0.83%) ▼|CRM244.16-4.96 (-1.99%) ▼|CSCO109.43+0.26 (+0.24%) ▲|CVS95.38-0.69 (-0.72%) ▼|CVX213.81+4.01 (+1.91%) ▲|DE677.21-3.52 (-0.52%) ▼|DHR204.85-0.38 (-0.19%) ▼|DIS104.18-0.88 (-0.84%) ▼|DUK120.43-0.81 (-0.67%) ▼|EMR150.34-1.81 (-1.19%) ▼|FDX309.19-4.94 (-1.57%) ▼|GD352.67-3.91 (-1.10%) ▼|GE325.42-9.49 (-2.83%) ▼|GEV951.04-20.27 (-2.09%) ▼|GILD145.65-0.99 (-0.68%) ▼|GM83.76-2.03 (-2.37%) ▼|GOOG328.38-7.00 (-2.09%) ▼|GOOGL330.65-7.71 (-2.28%) ▼|GS1,028.78-7.75 (-0.75%) ▼|HD310.45-3.25 (-1.04%) ▼|HON204.93-3.31 (-1.59%) ▼|IBM239.94+7.85 (+3.38%) ▲|INTC106.24+1.77 (+1.69%) ▲|INTU313.94-4.99 (-1.56%) ▼|ISRG353.24+3.08 (+0.88%) ▲|JNJ267.08-2.04 (-0.76%) ▼|JPM354.71+1.20 (+0.34%) ▲|KO87.55-0.81 (-0.92%) ▼|LIN466.65-1.73 (-0.37%) ▼|LLY1,124.21+0.30 (+0.03%) ▲|LMT524.46-11.69 (-2.18%) ▼|LOW198.60-2.20 (-1.10%) ▼|LRCX315.84-4.58 (-1.43%) ▼|MA567.50-3.39 (-0.59%) ▼|MCD253.48-2.33 (-0.91%) ▼|MDLZ62.42+0.79 (+1.28%) ▲|MDT91.89-0.50 (-0.54%) ▼|META653.69+40.21 (+6.55%) ▲|MMM164.40-3.12 (-1.86%) ▼|MO67.89-0.28 (-0.41%) ▼|MRK147.53-0.93 (-0.63%) ▼|MS215.35-0.89 (-0.41%) ▼|MSFT491.65-2.30 (-0.47%) ▼|MU1,027.77+27.51 (+2.75%) ▲|NEE82.65-1.18 (-1.41%) ▼|NFLX76.03-0.74 (-0.96%) ▼|NKE37.35-0.75 (-1.97%) ▼|NOW131.11-3.10 (-2.31%) ▼|NVDA223.67-2.06 (-0.91%) ▼|ORCL161.63-0.89 (-0.55%) ▼|PEP136.69-1.76 (-1.27%) ▼|PFE27.78-0.01 (-0.04%) ▼|PG142.64-2.94 (-2.02%) ▼|PLTR169.53-0.77 (-0.45%) ▼|PM185.71+0.98 (+0.53%) ▲|QCOM176.40+2.31 (+1.33%) ▲|RTX197.55-1.26 (-0.63%) ▼|SBUX100.04-1.97 (-1.93%) ▼|SCHW106.54-0.33 (-0.31%) ▼|SO88.34-0.65 (-0.73%) ▼|SPG204.53-5.10 (-2.43%) ▼|T25.15-0.45 (-1.76%) ▼|TMO605.69+2.67 (+0.44%) ▲|TMUS177.34-4.35 (-2.39%) ▼|TSLA367.81-0.35 (-0.10%) ▼|TXN261.59+2.67 (+1.03%) ▲|UBER71.08-2.05 (-2.80%) ▼|UNH393.06-7.78 (-1.94%) ▼|UNP284.74-3.71 (-1.29%) ▼|UPS99.22-1.26 (-1.25%) ▼|USB62.11-0.38 (-0.61%) ▼|V367.39-1.25 (-0.34%) ▼|VZ49.74-0.67 (-1.33%) ▼|WFC89.67+1.71 (+1.94%) ▲|WMT105.83-0.22 (-0.21%) ▼|XOM164.23+3.57 (+2.22%) ▲|AAPL315.34-0.88 (-0.28%) ▼|ABBV250.91+2.13 (+0.86%) ▲|ABT105.23-0.29 (-0.27%) ▼|ACN175.80-3.23 (-1.80%) ▼|ADBE254.86-2.40 (-0.93%) ▼|AMAT468.85-3.94 (-0.83%) ▼|AMD521.10+15.36 (+3.04%) ▲|AMGN391.27-1.90 (-0.48%) ▼|AMT175.43-0.30 (-0.17%) ▼|AMZN252.40-4.57 (-1.78%) ▼|AVGO364.38-4.18 (-1.13%) ▼|AXP321.80-4.30 (-1.32%) ▼|BA206.42-4.31 (-2.05%) ▼|BAC62.67+0.28 (+0.45%) ▲|BKNG173.43-6.87 (-3.81%) ▼|BLK1,072.03-23.34 (-2.13%) ▼|BMY64.41-0.28 (-0.43%) ▼|BNY162.51-0.34 (-0.21%) ▼|BRK-B506.72+0.89 (+0.18%) ▲|C137.80+1.06 (+0.78%) ▲|CAT815.56-6.92 (-0.84%) ▼|CL88.03-0.38 (-0.43%) ▼|CMCSA24.59-1.74 (-6.61%) ▼|COF210.86-3.10 (-1.45%) ▼|COP136.53+1.49 (+1.10%) ▲|COST902.60-7.58 (-0.83%) ▼|CRM244.16-4.96 (-1.99%) ▼|CSCO109.43+0.26 (+0.24%) ▲|CVS95.38-0.69 (-0.72%) ▼|CVX213.81+4.01 (+1.91%) ▲|DE677.21-3.52 (-0.52%) ▼|DHR204.85-0.38 (-0.19%) ▼|DIS104.18-0.88 (-0.84%) ▼|DUK120.43-0.81 (-0.67%) ▼|EMR150.34-1.81 (-1.19%) ▼|FDX309.19-4.94 (-1.57%) ▼|GD352.67-3.91 (-1.10%) ▼|GE325.42-9.49 (-2.83%) ▼|GEV951.04-20.27 (-2.09%) ▼|GILD145.65-0.99 (-0.68%) ▼|GM83.76-2.03 (-2.37%) ▼|GOOG328.38-7.00 (-2.09%) ▼|GOOGL330.65-7.71 (-2.28%) ▼|GS1,028.78-7.75 (-0.75%) ▼|HD310.45-3.25 (-1.04%) ▼|HON204.93-3.31 (-1.59%) ▼|IBM239.94+7.85 (+3.38%) ▲|INTC106.24+1.77 (+1.69%) ▲|INTU313.94-4.99 (-1.56%) ▼|ISRG353.24+3.08 (+0.88%) ▲|JNJ267.08-2.04 (-0.76%) ▼|JPM354.71+1.20 (+0.34%) ▲|KO87.55-0.81 (-0.92%) ▼|LIN466.65-1.73 (-0.37%) ▼|LLY1,124.21+0.30 (+0.03%) ▲|LMT524.46-11.69 (-2.18%) ▼|LOW198.60-2.20 (-1.10%) ▼|LRCX315.84-4.58 (-1.43%) ▼|MA567.50-3.39 (-0.59%) ▼|MCD253.48-2.33 (-0.91%) ▼|MDLZ62.42+0.79 (+1.28%) ▲|MDT91.89-0.50 (-0.54%) ▼|META653.69+40.21 (+6.55%) ▲|MMM164.40-3.12 (-1.86%) ▼|MO67.89-0.28 (-0.41%) ▼|MRK147.53-0.93 (-0.63%) ▼|MS215.35-0.89 (-0.41%) ▼|MSFT491.65-2.30 (-0.47%) ▼|MU1,027.77+27.51 (+2.75%) ▲|NEE82.65-1.18 (-1.41%) ▼|NFLX76.03-0.74 (-0.96%) ▼|NKE37.35-0.75 (-1.97%) ▼|NOW131.11-3.10 (-2.31%) ▼|NVDA223.67-2.06 (-0.91%) ▼|ORCL161.63-0.89 (-0.55%) ▼|PEP136.69-1.76 (-1.27%) ▼|PFE27.78-0.01 (-0.04%) ▼|PG142.64-2.94 (-2.02%) ▼|PLTR169.53-0.77 (-0.45%) ▼|PM185.71+0.98 (+0.53%) ▲|QCOM176.40+2.31 (+1.33%) ▲|RTX197.55-1.26 (-0.63%) ▼|SBUX100.04-1.97 (-1.93%) ▼|SCHW106.54-0.33 (-0.31%) ▼|SO88.34-0.65 (-0.73%) ▼|SPG204.53-5.10 (-2.43%) ▼|T25.15-0.45 (-1.76%) ▼|TMO605.69+2.67 (+0.44%) ▲|TMUS177.34-4.35 (-2.39%) ▼|TSLA367.81-0.35 (-0.10%) ▼|TXN261.59+2.67 (+1.03%) ▲|UBER71.08-2.05 (-2.80%) ▼|UNH393.06-7.78 (-1.94%) ▼|UNP284.74-3.71 (-1.29%) ▼|UPS99.22-1.26 (-1.25%) ▼|USB62.11-0.38 (-0.61%) ▼|V367.39-1.25 (-0.34%) ▼|VZ49.74-0.67 (-1.33%) ▼|WFC89.67+1.71 (+1.94%) ▲|WMT105.83-0.22 (-0.21%) ▼|XOM164.23+3.57 (+2.22%) ▲|
24.6 C
New York
Thursday, September 10, 2026

Tag: companies

newssourceFORcompanyinformationcontent1releasesmarket

Global Education and Business Leaders Witnessed Learning Innovation at D2L Fusion 2025

D2L announced Createspace, Accessibility+, and enhancements to D2L Brightspace and D2L Lumi at annual user conference TORONTO, July 24, 2025 /PRNewswire/ - D2L, a global learning innovation...

Global Education and Business Leaders Witnessed Learning Innovation at D2L Fusion 2025

D2L announced Createspace, Accessibility+, and enhancements to D2L Brightspace and D2L Lumi at annual user conference TORONTO, July 24, 2025 /CNW/ - D2L, a global learning innovation...

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...

Dickey’s Barbecue Pit Responds to Frivolous, False Lawsuit Claims

DALLAS, July 24, 2025 /PRNewswire/ -- Dickey's Barbecue Restaurants, Inc. has issued a statement in response to a lawsuit filed by a former Houston franchisee,...

Nelnet Introduces Propelr, an Employee Learning Company Committed to Launching Workforce Potential

LINCOLN, Neb., July 24, 2025 /PRNewswire/ -- Nelnet Business Services, a division of Nelnet, Inc. (NYSE: NNI), announces the launch of a new company, Propelr,...

Meridian Corporation Reports Second Quarter 2025 Results and Announces a Quarterly Dividend of $0.125 per Common Share

MALVERN, Pa., July 24, 2025 (GLOBE NEWSWIRE) -- Meridian Corporation (Nasdaq: MRBK) today reported:

Boise to welcome up to 50,000 for Basque festival

BOISE, Idaho, July 24, 2025 /PRNewswire/ -- Every five years, Idaho's state capital becomes the Basque capital of America as up to 50,000 of...

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding

Commack, NY, July 24, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, today announced that its board of directors has approved a bridge funding raise of up to an aggregate amount of $3 million, of which it has secured approximately $1.2 million, through the issuance of shares of the Company’s common stock to institutional or accredited investors.

Ovintiv Reports Second Quarter 2025 Financial and Operating Results

Full Year Capital Guidance Lowered; Production Guidance Increased Highlights: Generated cash from operating activities of $1,013 million, Non-GAAP Cash Flow of $913 million and Non-GAAP Free...

GLOBAL X ANNOUNCES JULY 2025 DISTRIBUTIONS FOR ITS SUITE OF ETFs

TORONTO, July 24, 2025 /CNW/ - Global X Investments Canada Inc. ("Global X") is pleased to announce the distribution amounts per security (the "Distributions") for...

Gold Royalty Reports Record Revenue in the Second Quarter 2025

VANCOUVER, BC, July 24, 2025 /CNW/ - Gold Royalty Corp. ("Gold Royalty" or the "Company") (NYSE American: GROY) is pleased to announce its preliminary...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompanies

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers